Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (5): 312-313.
Previous Articles Next Articles
PANG Li-feng
Received:2018-01-15
Revised:2018-06-21
Online:2018-05-20
Published:2018-06-21
CLC Number:
PANG Li-feng . One Case of Coagulation Abnormalities Induced by Cefoperazone Sodium and Sulbactam Sodium for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 312-313.
| [1] 周群.注射用头孢哌酮钠/舒巴坦钠不良反应文献分析[J]. 中国药房,2010,21(22):2093-2095. [2] 陈文彬,潘祥林.诊断学[M]. 8版. 北京:人民卫生出版社,2013:291-292. [3] Naranjo C A, Busto U, Sellers E M, et al. A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther，1981，30(2):239-245. [4] 王宇,丁宁.单用头孢哌酮钠舒巴坦钠致凝血功能异常的临床分析及对策[J]. 临床和实验医学杂志,2015,14(16):1397-1399. [5] Strom B L, Schinnar R, Gibson G A, et al. Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics:using cefoperazone as a test case[J].Pharmacoepidemiol Drug Saf，1999，8(2):81-94. [6] 娄丽丽,赵旭,王思睿,等.舒普深致中重症胰腺炎严重凝血功能障碍1例报告[J]. 临床肝胆病杂志,2017,33(1):167-168. [7] 李颖,胡永芳,彭芳辰.头孢哌酮舒巴坦引起血小板减少的循证分析[J]. 中国药学杂志,2009,44(23):1938-1941. [8] 刘宪军,付娜.109例头孢哌酮钠舒巴坦钠不良反应报告分析[J]. 中国药物警戒,2014,11(6):355-357. [9] 戴晓琴,马纯雪,蔡月,等.头孢哌酮钠舒巴坦钠致凝血功能异常的危险因素分析及护理[J].护理学报,2013,20(5A):59-61. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
